Embolic Protection Devices in Transcatheter Aortic Valve Replacement

Area of Science:

• Cardiovascular Surgery
• Neurology
• Biomedical Engineering

Background:

• Transcatheter aortic valve replacement (TAVR) is associated with periprocedural neurological events.
• This concern spurred the development of embolic protection devices (EPDs).

Purpose of the Study:

• To review current clinical research on EPDs used during TAVR.
• To highlight the limitations and caveats of existing studies.

Main Methods:

• Review of ongoing clinical trials and research on EPDs.
• Analysis of study designs focusing on surrogate markers.

Main Results:

• Current EPD research often uses silent central nervous system lesions on MRI and cognitive function as primary endpoints.
• The correlation between these surrogate markers and actual clinical outcomes like stroke or quality of life is not well-established.

Conclusions:

• The clinical utility of EPDs in TAVR is not yet definitively proven.
• Interpretation of study results should consider the limitations of surrogate markers and their relevance to real-world patient benefit.